Augusta University
Allison BrownPublished in Oncotarget, researchers led by Dr. Shuang Huang have identified a currently available drug that may benefit a subset of ovarian cancer patients. Results of GRU Cancer Center’s Drs. Huang and Han-Fei Ding and their collaborators show...
Through a collaboration between the GRU Vascular Biology Center and the GRU Cancer Center, a novel therapeutic approach called ‘biased signaling’ has been brought from the cardiovascular field to that of ovarian cancer. The concept is based on the...
Human Ovarian Cancer Stroma Contains Luteinized Theca Cells Harboring Tumor Suppressor Gene GT198 Mutations. Citation: Peng M, Zhang H, Jaafar L, Risinger JI, Huang S, Mivechi NF, Ko L. Human Ovarian Cancer Stroma Contains Luteinized Theca...